{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:10:19Z","timestamp":1759590619270,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clineuro.2020.106047","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T12:02:49Z","timestamp":1593000169000},"page":"106047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Radiological characteristics of neuromyelitis optica spectrum disorder in Kuwait"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-7044","authenticated-orcid":false,"given":"Ismail Ibrahim","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-9219","authenticated-orcid":false,"given":"Samar Farouk","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasem Y.","family":"Al-Hashel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab A.","family":"Abdelnabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed","family":"Alroughani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2020.106047_bib0005","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2020.106047_bib0010","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","article-title":"Aquaporin-4 autoimmunity","volume":"2","author":"Zekeridou","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2020.106047_bib0015","first-page":"1033","article-title":"My\u00e9lite aigu\u00eb compliqu\u00e9e de n\u00e9vrite optique","volume":"8","author":"Devic","year":"1894","journal-title":"Bull Med (Paris)"},{"issue":"2","key":"10.1016\/j.clineuro.2020.106047_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.106047_bib0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1352458513506953","article-title":"The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders","volume":"20","author":"Huh","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2018.08.014","article-title":"Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta","volume":"324","author":"Salama","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106047_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: a multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0040","first-page":"295","article-title":"Neuromyelitis optica and neuromyelitis optica-IgG seropositivity in Saudis with demyelinating diseases of the central nervous system","volume":"19","author":"Al-Khathaami","year":"2014","journal-title":"Neurol. Asia"},{"key":"10.1016\/j.clineuro.2020.106047_bib0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.msard.2019.02.012","article-title":"Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort","volume":"30","author":"Bennis","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clineuro.2020.106047_bib0050","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jns.2017.08.3254","article-title":"Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: clinical and paraclinical characteristics in Algerian patients","volume":"381","author":"Bouzar","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2020.106047_bib0055","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1177\/1352458514537699","article-title":"An epidemiological study of neuromyelitis optica in Isfahan","volume":"20","author":"Etemadifar","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0060","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0065","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0070","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: a multicenter study of 125 patients","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.106047_bib0075","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp-2011-300403","article-title":"Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes","volume":"82","author":"Nagaishi","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2020.106047_bib0080","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2020.106047_bib0085","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2020.106047_bib0090","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2020.106047_bib0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.25411","article-title":"Brain and cord imaging features in neuromyelitis optica spectrum disorders","volume":"85","author":"Cacciaguerra","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.11.030","article-title":"Epidemiology of neuromyelitis optica spectrum disorders patients in Kuwait","volume":"37","author":"Ahmed","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clineuro.2020.106047_bib0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archophthalmol.2007.26","article-title":"Clinical course of optic neuritis in patients with relapsing neuromyelitis optica","volume":"126","author":"Papais-Alvarenga","year":"2008","journal-title":"Arch. Ophthalmol."},{"issue":"1-2","key":"10.1016\/j.clineuro.2020.106047_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2015.05.013","article-title":"Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis","volume":"355","author":"Mealy","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2020.106047_bib0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.clineuro.2020.106047_bib0120","article-title":"Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis","volume":"4","author":"Srikajon","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.clineuro.2020.106047_bib0125","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1352458516674366","article-title":"Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G","volume":"23","author":"Kim","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-13-33","article-title":"Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study","volume":"13","author":"Asgari","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0145","article-title":"Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder","author":"Nakamura","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum Disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0155","article-title":"Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity","author":"hien","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0160","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00330-009-1425-3","article-title":"Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study","volume":"19","author":"Krampla","year":"2009","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0165","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00415-013-6997-9","article-title":"Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies","volume":"260","author":"Iorio","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0170","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","article-title":"Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies","volume":"70","author":"Kitley","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1352458512451659","article-title":"Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies","volume":"19","author":"Chang","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/cen3.12501","article-title":"Magnetic resonance imaging diagnosis of demyelinating diseases: an update","volume":"10","author":"Miki","year":"2019","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0185","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3174\/ajnr.A5551","article-title":"MRI features of aquaporin-4 antibody-positive longitudinally extensive transverse myelitis: insights into the diagnosis of neuromyelitis optica spectrum disorders","volume":"39","author":"Chee","year":"2018","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.2008.01012.x","article-title":"Brain magnetic resonance imaging abnormalities in neuromyelitis optica","volume":"118","author":"Li","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2020.106047_bib0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejrad.2010.06.024","article-title":"Brain MRI abnormalities in neuromyelitis optica","volume":"80","author":"Wang","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12883-014-0218-8","article-title":"Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients","volume":"14","author":"Liao","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0205","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.106047_bib0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-13-33","article-title":"Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a populationbased, descriptive study","volume":"13","author":"Asgari","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/rg.2018170141","article-title":"Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis","volume":"38","author":"Dutra","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.clineuro.2020.106047_bib0220","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1352458510376640","article-title":"Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity","volume":"16","author":"Kim","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1352458506070725","article-title":"Brain magnetic resonance imaging findings in relapsing neuromyelitis optica","volume":"13","author":"Cabrera-Gomez","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0230","article-title":"Brain abnormalities in neuromyelitis optica spectrum disorder","volume":"2012","author":"Kim","year":"2012","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.clineuro.2020.106047_bib0235","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneurol.2011.249","article-title":"Brain involvement in neuromyelitis optica spectrum disorders","volume":"68","author":"Chan","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0240","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3174\/ajnr.A5663","article-title":"Imaging differences between neuromyelitis optica spectrum disorders and multiple sclerosis: a multi\u2010institutional study in Japan","volume":"39","author":"Tatekawa","year":"2018","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-017-1682-1","article-title":"Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clineuro.2020.106047_bib0250","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1352458509103301","article-title":"Occurrence of acute large and edematous callosal lesions in neuromyelitis optica","volume":"15","author":"Nakamura","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2020.106047_bib0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.msard.2019.04.019","article-title":"Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis","volume":"32","author":"Cai","year":"2019","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720303905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720303905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:35:34Z","timestamp":1759588534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720303905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"alternative-id":["S0303846720303905"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106047","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiological characteristics of neuromyelitis optica spectrum disorder in Kuwait","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106047"}}